About vaccines

About vaccines

589 bookmarks
Custom sorting
Vaccination may protect against SARS-CoV-2 infection at the eye surface
Vaccination may protect against SARS-CoV-2 infection at the eye surface
Researchers in Australia have conducted a study showing that vaccination against coronavirus disease 2019 (COVID-19) induces key antibodies at the eye surface that may help to protect against the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). // 5.8.2021
·news-medical.net·
Vaccination may protect against SARS-CoV-2 infection at the eye surface
COVID vaccines generate antibodies in saliva
COVID vaccines generate antibodies in saliva
Researchers in the United States and Canada have conducted a study showing that the vaccines developed by Pfizer-BioNTech and Moderna to protect against coronavirus disease 2019 (COVID-19) generate local antibody responses in the salivary gland that are independent of the systemic immune response.// 5.8.2021
·news-medical.net·
COVID vaccines generate antibodies in saliva
COVID-19 vaccine surveillance report published
COVID-19 vaccine surveillance report published
National coronavirus (COVID-19) vaccine surveillance report, including estimated number of hospitalisations and deaths prevented.
·gov.uk·
COVID-19 vaccine surveillance report published
Coronavirus (COVID-19) Infection Survey technical article - Office for National Statistics
Coronavirus (COVID-19) Infection Survey technical article - Office for National Statistics
This analysis provides data about positivity after vaccination from the Coronavirus (COVID-19) Infection Survey. This analysis has been produced in partnership with University of Oxford. // July Tartunnan riski tippuu radikaalisti 21 päivää ekan rokotuksen jälkeen ja että jos saavat tartunnan on tartunta oireeton tai vähäoireinen ja viruskuorma pienempi
·ons.gov.uk·
Coronavirus (COVID-19) Infection Survey technical article - Office for National Statistics
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study
Objectives Highly effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed but variants of concerns (VOCs) with mutations in the spike protein are worrisome, especially B.1.617.2 (Delta) which has rapidly spread across the world. // 31.7.2021
·medrxiv.org·
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study
”Olen pahoillani, on liian myöhäistä” – amerikkalaislääkäri kertoo, millaista on hoitaa kuolevia, rokotukset väliin jättäneitä potilaita
”Olen pahoillani, on liian myöhäistä” – amerikkalaislääkäri kertoo, millaista on hoitaa kuolevia, rokotukset väliin jättäneitä potilaita
Amerikkalaislääkäri jakoi koskettavassa päivityksessään kokemuksiaan kuolemaa tekevien koronapotilaiden parissa. // 22.7.2021
·iltalehti.fi·
”Olen pahoillani, on liian myöhäistä” – amerikkalaislääkäri kertoo, millaista on hoitaa kuolevia, rokotukset väliin jättäneitä potilaita
‘I’m sorry, but it’s too late’: Alabama doctor tells unvaccinated, dying COVID patients
‘I’m sorry, but it’s too late’: Alabama doctor tells unvaccinated, dying COVID patients
“And now all you really see is their fear and their regret. And even though I may walk into the room thinking, ‘Okay, this is your fault, you did this to yourself,’ when I leave the room, I just see a person that's really suffering, and that is so regretful for the choice that they made.” // 21.7.2021
·al.com·
‘I’m sorry, but it’s too late’: Alabama doctor tells unvaccinated, dying COVID patients